Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IBEX Technologies Inc V.IBT

Healthcare Biotechnology
IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.


TSXV:IBT - Post by User

IBEX Technologies Inc > Just how poor is Ibex's PR ?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(265)
•••
Post by guarantor1on Dec 17, 2020 6:40am
108 Views
Post# 32126103

Just how poor is Ibex's PR ?

Just how poor is Ibex's PR ?Go to Ibex's website and click "Investors"...

1, No Event Presentations - have never seen Ibex presentng anything, anytime, anywhere
2. They only link News for 2 years...which is kind of unique
3. They don't link all news- for example the only News (other than financials) that is linked is that they intend to sell their US property, back in March 2019. Missed a few
4. They haven't bothered to link their Q1 Financials, that were released last week

How poor ?
pisss poor, imo
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities